FDA Approved Drugs Repurposing of Toll-Like Receptor4 (TLR4) Candidate for Neuropathy

Accumulating evidence indicates that toll-like receptor 4 (TLR4) plays a critical role in promoting adaptive immune responses and are definitively involved in the expansion and maintenance of the neuropathic pain. Though the application of docking in virtual-screening in silico methods to drug disco...

Descripción completa

Detalles Bibliográficos
Autores principales: Zali, Hakimeh, Golchin, Ali, Farahani, Masoumeh, Yazdani, Mohsen, Ranjbar, Mohammad Mehdi, Dabbagh, Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934974/
https://www.ncbi.nlm.nih.gov/pubmed/32641971
http://dx.doi.org/10.22037/ijpr.2019.2394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934974/
https://www.ncbi.nlm.nih.gov/pubmed/32641971
http://dx.doi.org/10.22037/ijpr.2019.2394

Ejemplares similares